Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA1 | P42261 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | Q9HBH1 | 1/20 | 0.32 | |
| ▸ | NPY4R | P50391 | 2/20 | 0.32 |
| ▸ | NPY1R | P25929 | 1/20 | 0.32 |
| ▸ | TGM2 | P21980 | 1/20 | 0.32 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.31 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.31 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.31 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.30 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18464241 | 0.84 | NPY4R (0.42) | GRIA1MEN1GAAKMT2APDF | |
| SCHEMBL18876681 | 0.80 | CA1 (0.40) | PDFERAP1LNPEPCA1CA2 | |
| Hydrochloric Acid SCHEMBL28675934 | 0.72 | CTSK (0.43) | ERAP1LNPEP | |
| Hydrochloric Acid SCHEMBL28675933 | 0.72 | CTSK (0.43) | ERAP1LNPEP | |
| SCHEMBL18880201 | 0.72 | CA1 (0.38) | PDFCA1CA2 | |
| SCHEMBL4552682 | 0.70 | FOLH1 (0.40) | GRIA1MEN1GAAKMT2ANPY4R | |
| SCHEMBL1724846 | 0.70 | FOLH1 (0.40) | GRIA1MEN1GAAKMT2ANPY4R | |
| SCHEMBL22460551 | 0.68 | MEN1 (0.54) | MEN1GAAKMT2ACA1CA2 | |
| SCHEMBL22460550 | 0.68 | MEN1 (0.54) | MEN1GAAKMT2ACA1CA2 | |
| SCHEMBL12989830 | 0.68 | ALOX15 (0.40) | MEN1KMT2ATGM2SIRT2SIRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10988444-B2 | Antimicrobial compounds | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2021-04-27 | — | — | US | disclosed |
| US-20190256466-A1 | ANTIMICROBIAL COMPOUNDS | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2019-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190256466-A1 | ANTIMICROBIAL COMPOUNDS | MPO, CFTR, MMP8 | GRIA1 4245/4885MEN1 3424/4885GAA 294/4885 |
| US-10988444-B2 | Antimicrobial compounds | MPO, CFTR, MMP8 | GRIA1 4245/4885MEN1 3424/4885GAA 294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.